{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:15:31Z","timestamp":1789143331466,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117216","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:34:17Z","timestamp":1785900857000},"page":"117216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Vorinostat ameliorates cognitive impairment and Tau pathology in an AAV-P301L-Tau-induced tauopathy mouse model: insights into neuroinflammation and PI3K\/AKT\/GSK3\u03b2 signaling"],"prefix":"10.1016","volume":"187","author":[{"given":"Zhidan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3564-8862","authenticated-orcid":false,"given":"Ling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117216_bb0005","first-page":"3708","article-title":"Alzheimer\u2019s disease facts and figures","volume":"20","author":"Alzheimer\u2019s Dement","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.intimp.2026.117216_bb0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/1570159X19666210826130210","article-title":"Neuroinflammatory signaling in the pathogenesis of Alzheimer\u2019s disease","volume":"20","author":"Uddin","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.intimp.2026.117216_bb0015","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","article-title":"The cost of Alzheimer\u2019s disease in China and re-estimation of costs worldwide","volume":"14","author":"Jia","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.intimp.2026.117216_bb0020","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/ijms23041989","article-title":"Aging, cellular senescence, and Alzheimer\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117216_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13195-024-01656-9","article-title":"Exploring sex differences in Alzheimer\u2019s disease: a comprehensive analysis of a large patient cohort from a memory unit","volume":"17","author":"Rosende-Roca","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.intimp.2026.117216_bb0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.intimp.2026.117216_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","article-title":"\u03b2-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease","volume":"12","author":"Gouras","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.intimp.2026.117216_bb0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0072-9752(07)01223-7","article-title":"Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer\u2019s disease","volume":"89","author":"Selkoe","year":"2008","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.intimp.2026.117216_bb0045","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.intimp.2026.117216_bb0050","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3233\/JAD-220132","article-title":"A Bayesian reanalysis of the phase III Aducanumab (ADU) trial","volume":"87","author":"Costa","year":"2022","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.intimp.2026.117216_bb0055","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3233\/JAD-231362","article-title":"Remote associations between tau and cortical amyloid-\u03b2 are stage-dependent","volume":"98","author":"Hojjati","year":"2024","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.intimp.2026.117216_bb0060","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and tau with Cognition in preclinical Alzheimer disease: a longitudinal study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.intimp.2026.117216_bb0065","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ana.25878","article-title":"Sex mediates relationships between regional tau pathology and cognitive decline","volume":"88","author":"Buckley","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.117216_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13195-025-01684-z","article-title":"Sex differences in the association of Alzheimer\u2019s disease biomarkers and cognition in a multicenter memory clinic study","volume":"17","author":"Boccalini","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.intimp.2026.117216_bb0075","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.24135","article-title":"Sex modifies the APOE-related risk of developing Alzheimer disease","volume":"75","author":"Altmann","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.117216_bb0080","doi-asserted-by":"crossref","unstructured":"Koran MEI, Wagener M, Hohman TJ, Alzheimer's Neuroimaging Initiative (2017) Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behav. 11:205\u2013213. Doi: https:\/\/doi.org\/10.1007\/s11682-016-9523-8.","DOI":"10.1007\/s11682-016-9523-8"},{"key":"10.1016\/j.intimp.2026.117216_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104052","article-title":"Restoring the epigenome in Alzheimer\u2019s disease: advancing HDAC inhibitors as therapeutic agents","volume":"29","author":"Pereira","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.intimp.2026.117216_bb0090","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"Glozak","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2026.117216_bb0095","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00018-019-03098-1","article-title":"Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy","volume":"76","author":"Patra","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2026.117216_bb0100","doi-asserted-by":"crossref","first-page":"9573","DOI":"10.1007\/s12035-025-04866-w","article-title":"HDAC3 as an emerging therapeutic target for Alzheimer\u2019s disease and other neurological disorders","volume":"62","author":"Li","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117216_bb0105","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2011.01575.x","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage","volume":"165","author":"Chen","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117216_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110429","article-title":"Assessment of suberoylanilide hydroxamic acid on a Alzheimer\u2019s disease model induced by \u03b2-amyloid(1-42) in aged female mice: Neuromodulatory and epigenetic effect","volume":"375","author":"Athaide Rocha","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.intimp.2026.117216_bb0115","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bbi.2025.03.008","article-title":"Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model","volume":"127","author":"Silva-Llanes","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.intimp.2026.117216_bb0120","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.ajpath.2011.06.025","article-title":"Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration","volume":"179","author":"Jaworski","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2026.117216_bb0125","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/NEN.0000000000000006","article-title":"A rapid gene delivery-based mouse model for early-stage Alzheimer disease-type tauopathy","volume":"72","author":"Siman","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.intimp.2026.117216_bb0130","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12017-021-08660-4","article-title":"Repurposing Vorinostat for the treatment of disorders affecting brain","volume":"23","author":"Athira","year":"2021","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.intimp.2026.117216_bb0135","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2026.117216_bb0140","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/13872877251352107","article-title":"Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer\u2019s disease mouse model","volume":"106","author":"Bose","year":"2025","journal-title":"Journal of Alzheimer\u2019s disease\u202f: JAD"},{"key":"10.1016\/j.intimp.2026.117216_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10522-025-10236-9","article-title":"Vorinostat, a potential hormetin, extends lifespan and enhances stress resistance via the SKN-1 pathway in Caenorhabditis elegans","volume":"26","author":"Huang","year":"2025","journal-title":"Biogerontology"},{"key":"10.1016\/j.intimp.2026.117216_bb0150","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/s41586-019-1329-6","article-title":"Author correction: single-cell transcriptomic analysis of Alzheimer\u2019s disease","volume":"571","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2026.117216_bb0155","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1016\/j.cell.2022.09.002","article-title":"X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women","volume":"185","author":"Yan","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2026.117216_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12802","article-title":"Aging and Alzheimer\u2019s disease: comparison and associations from molecular to system level","volume":"17","author":"Xia","year":"2018","journal-title":"Aging Cell"},{"key":"10.1016\/j.intimp.2026.117216_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116810","article-title":"Dual-target inhibitors based on acetylcholinesterase: novel agents for Alzheimer\u2019s disease","volume":"279","author":"Zhao","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.intimp.2026.117216_bb0170","first-page":"1","article-title":"Galantamine-ER for the treatment of mild-to-moderate Alzheimer\u2019s disease","volume":"5","author":"Seltzer","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.intimp.2026.117216_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1025473","article-title":"The role of altered protein acetylation in neurodegenerative disease","volume":"14","author":"Kabir","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.intimp.2026.117216_bb0180","article-title":"HDAC inhibitor attenuates rat traumatic brain injury induced neurological impairments","volume":"9","author":"Lu","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2026.117216_bb0185","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1021\/acschemneuro.0c00315","article-title":"Cognitive improvement by Vorinostat through modulation of endoplasmic reticulum stress in a corticosterone-induced chronic stress model in mice","volume":"11","author":"K V A","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.intimp.2026.117216_bb0190","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41386-018-0143-4","article-title":"Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity","volume":"44","author":"de la Fuente","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2026.117216_bb0195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/WNR.0000000000001196","article-title":"Suberoylanilide hydroxamic acid reversed cognitive and synaptic plasticity impairments induced by sevoflurane exposure in adult mice","volume":"30","author":"Zhang","year":"2019","journal-title":"Neuroreport"},{"key":"10.1016\/j.intimp.2026.117216_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117031","article-title":"Qingxin Kaiqiao Fang decreases tau hyperphosphorylation in Alzheimer\u2019s disease via the PI3K\/Akt\/GSK3\u03b2 pathway in vitro and in vivo","volume":"318","author":"Liu","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.117216_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117216_bb0210","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1007\/s12035-022-02850-2","article-title":"Cryptotanshinone attenuates amyloid-\u03b242-induced tau phosphorylation by regulating PI3K\/Akt\/GSK3\u03b2 pathway in HT22 cells","volume":"59","author":"Lyu","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.intimp.2026.117216_bb0215","first-page":"1505","article-title":"Neuroprotective effect of sinapic acid in APP\/PS1 mouse model and PC12 cells of Alzheimer\u2019s disease via activation of PI3K\/Akt\/GSK3\u03b2 signaling pathways","volume":"37","author":"Xue","year":"2024","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.intimp.2026.117216_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118664","article-title":"Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease","volume":"1867","author":"Lauretti","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.intimp.2026.117216_bb0225","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.21476","article-title":"Glycogen synthase kinase-3beta and tau genes interact in Alzheimer\u2019s disease","volume":"64","author":"Kwok","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2026.117216_bb0230","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13293-025-00697-5","article-title":"Mapping the hippocampal spatial proteomic signature in male and female mice of an early Alzheimer\u2019s disease model","volume":"16","author":"Contreras","year":"2025","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.intimp.2026.117216_bb0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-231444","article-title":"The Association of Brain Insulin Resistance with anesthesia\/surgery-induced cognitive deterioration is female-specific in 5XFAD transgenic mice","volume":"101","author":"Zhang","year":"2024","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.intimp.2026.117216_bb0240","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2019.03.001","article-title":"Role of the PI3K\/AKT (mTOR and GSK3\u03b2) signalling pathway and photobiomodulation in diabetic wound healing","volume":"50","author":"Jere","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2026.117216_bb0245","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141848","article-title":"Age-related GSK3\u03b2 overexpression drives podocyte senescence and glomerular aging","volume":"132","author":"Fang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117216_bb0250","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2121-2-12","article-title":"Glycogen synthase kinase3 beta phosphorylates serine 33 of p53 and activates p53\u2019s transcriptional activity","volume":"2","author":"Turenne","year":"2001","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.intimp.2026.117216_bb0255","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.117216_bb0260","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.celrep.2018.04.097","article-title":"Modeling late-onset sporadic Alzheimer\u2019s disease through BMI1 deficiency","volume":"23","author":"Flamier","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.117216_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-03312-0","article-title":"METTL14-regulated PI3K\/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial-mesenchymal transition of renal tubular cells in diabetic kidney disease","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117216_bb0270","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1002\/jcp.30337","article-title":"HDAC inhibition prevents hypobaric hypoxia-induced spatial memory impairment through P\u03993K\/GSK3\u03b2\/CREB pathway","volume":"236","author":"Kumar","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2026.117216_bb0275","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.7150\/thno.82535","article-title":"The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation","volume":"13","author":"Zhong","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2026.117216_bb0280","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-018-1193-6","article-title":"Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-\u03baB pathway dependent of HDAC3","volume":"15","author":"Chen","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.intimp.2026.117216_bb0285","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/nar\/gkn150","article-title":"Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5","volume":"36","author":"Hattori","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117216_bb0290","article-title":"A computational framework to characterize the Cancer drug induced effect on aging using transcriptomic data","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117216_bb0295","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1038\/s41598-025-95624-4","article-title":"Vorinostat attenuates UVB-induced skin senescence by modulating NF-\u03baB and mTOR signaling pathways","volume":"15","author":"Dai","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117216_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069964","article-title":"SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition","volume":"8","author":"Hanson","year":"2013","journal-title":"PloS One"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926010623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:05:08Z","timestamp":1789142708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926010623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":60,"alternative-id":["S1567576926010623"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117216","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vorinostat ameliorates cognitive impairment and Tau pathology in an AAV-P301L-Tau-induced tauopathy mouse model: insights into neuroinflammation and PI3K\/AKT\/GSK3\u03b2 signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117216"}}